Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-24 @ 5:23 PM
NCT ID:
NCT02650050
Eligibility Criteria:
Inclusion Criteria:
* 18 years or more
* macular edema associated with a 1 or type 2 diabetes with a hemoglobin A1C level over 5.5% and under \<13%
* indication for a treatment with intra-vitreal injections of ranibizumab
Exclusion Criteria:
* treatment with anti-VEGF during the previous 2 months
* treatment by intra-vitreous implant of dexamethasone during the previous six months
* previous history of vitrectomy or glaucoma
* photocoagulation during the previous 3 months
* patient's opposition to participate to the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02650050
Study Brief:
Protocol Section:
NCT02650050